COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study
Hussein, N. R.; Balatay, A.; Naqid, I. A.; Jamal, S. A.; Rasheed, N. A.; Ahmed, A. N.; Salih, R. S.; Mahdi, A. S.; Mansour, S. A.; Mahdi, S.; Ibrahim, N.; Musa, D. H.; Saleem, Z. S.
Show abstract
ObjectiveThis population-based study aimed to evaluate the seroprevalence of antibodies to SARS-CoV-2 in Duhok City, Kurdistan Region of Iraq. MethodsWe analyzed the national COVID-19 database that contains data regarding COVID-19 testing, management, and clinical outcomes in Duhok. For this study, different subdistricts within each district of Duhok were considered distinct clusters. Blood samples were collected from and questionnaires were administered to eligible and consenting participants who were members of different families from the subdistricts. Immunoassays were conducted to detect antibodies against SARS-CoV-2, and the associations between certain variables were investigated. ResultsThe average number cases of COVID-19 before November 2020 was 23141 {+/-} 4364, which was significantly higher than the average number of cases between November 2020 and February 2021 (3737 {+/-} 2634; P = 0.001). A total of 743 individuals agreed to participate and were enrolled in the study. Among the participants, 465/743 (62.58%) were found to have antibodies against severe acute respiratory syndrome coronavirus 2. Among the participants with antibodies, 262/465 (56.34%) denied having any history of COVID-19-related symptoms. The most common symptom was fever (81.77%), followed by myalgia (81.28%). We found that antibody levels increased steadily with age (Pearson correlation coefficient = 0.117; P = 0.012). A significant association was found between antibody levels and the presence of symptoms (P = 0.023; odds ratio = 1.0023; 95% confidence interval = 1.0002-1.0061). ConclusionsA significant reduction in the number of COVID-19 cases was observed. This might be due to the high prevalence of SARS-CoV-2 antibodies in Duhok. However, infection-prevention measures should be followed as it remains unclear whether acquired immunity is protective against reinfection. It expected that the infection rates during the next wave will not be as high as the first wave due to the high infection rate in the society.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Serological Survey in a university community after the fourth wave of COVID-19 in Senegal 97%
- Social distancing and preventive practices of government employees in response to COVID-19 in Ethiopia 97%
- Health-related quality of life of adult COVID-19 patients following one-month illness experience since diagnosis: findings of a cross-sectional study in Bangladesh 97%
Similar papers in this journal
Similar papers in this journal
- Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals 95%
- Live poultry feeding and trading network and the transmission of avian influenza A(H5N6) virus in a large city in China, 2014-2015 94%
- SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia 94%
Similar papers in this journal
Similar papers in this journal
- Trends and determinants of Acute Respiratory Infection symptoms among Under-five children in Cambodia: Analysis of 2000 to 2014 Cambodia Demographic and Health Surveys 96%
- Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African Republic 96%
- Primary care access and feasibility of Spatial Accessibility Index (SAI) in assessing primary care in rural Sri Lanka 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.